| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4441228
Max Phase: Preclinical
Molecular Formula: C19H16ClN3O
Molecular Weight: 337.81
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CN1c2ccccc2C(=O)N2CCn3c(cc4cc(Cl)ccc43)C21
Standard InChI: InChI=1S/C19H16ClN3O/c1-21-16-5-3-2-4-14(16)19(24)23-9-8-22-15-7-6-13(20)10-12(15)11-17(22)18(21)23/h2-7,10-11,18H,8-9H2,1H3
Standard InChI Key: ZQNLAPBHSZSONN-UHFFFAOYSA-N
Associated Targets(Human)
HCT-116 (91556 Activities)
MDA-MB-435 (38290 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
A549 (127892 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
topA DNA topoisomerase 1 (19 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 337.81 | Molecular Weight (Monoisotopic): 337.0982 | AlogP: 3.90 | #Rotatable Bonds: 0 |
| Polar Surface Area: 28.48 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.93 | CX LogD: 3.93 |
| Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.62 | Np Likeness Score: -0.90 |
References
| 1. Wang L, Fang K, Cheng J, Li Y, Huang Y, Chen S, Dong G, Wu S, Sheng C.. (2020) Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer., 63 (2): [PMID:31880942] [10.1021/acs.jmedchem.9b01626] |
Source
Source(1):